3rd Molecular Diagnostics for Cancer Drug Development

Venue: Inter City Hotel

Location: Frankfurt, Germany

Event Date/Time: Dec 05, 2011 End Date/Time: Dec 07, 2011
Report as Spam


What’s on the agenda?
Building on the huge success of Molecular Diagnostics for Cancer Drug Development in Boston, June 2011, this meeting is the perfect place to meet drug industry leaders and pioneering researchers from Europe to learn the latest approaches for stratifying patient populations with molecular diagnostics and how to increase your oncology drug programme’s chance of success. Here are just some of the topics we’ll be addressing at the meeting:
• The different MDx strategies companies are taking, both in large pharma and smaller drug developing companies: How are they going about trying to stratify patient populations in oncology?
• Who has run or is looking to prospectively run their clinical trial based on their biomarker? Who has retrospectively identified a biomarker that they are now integrating into clinical trials for patient stratification?
• How do we translate biomarkers from the laboratory to the clinic and achieve assay validation?
• How do we translate the complexity of cancer biology into a personalised test on a drug label? And what is the regulatory stance on this?
• How does the academic community and research fit into achieving personalised medicine in oncology?
• What are the latest tools and technologies for molecular profiling as we move away from genomics? Which kind of molecular markers will prove to be most predictive? And what are the diagnostic and clinical applications of next-generation sequencing?
• How do we ensure access to tissue samples needed for MDx, both in terms of using biorepositories and acquiring your own clinical samples?

Why attend?
Every presentation and contact will help you improve your research and business aims - everyone at the meeting is here to discuss how to predict response to oncology therapeutics and how to stratify patient populations for increased drug success.
Don't just listen to speakers and attendees - meet them and discuss your work in our intimate and informal conference setting. Plus, we'll make sure you meet everybody you want to in our dedicated speed networking session.
Receive tailored guidance on achieving patient stratification - our pre-conference workshops are a fantastic opportunity to get the information and contacts you need to achieve your research and business aims (over and above the inside information you will gain from the meeting itself).
Who's this meeting for?
Whether you are new to the field or expanding your existing capabilities around biomarker development and companion diagnostics, this meeting is a one-stop shop of the latest developments and strategies you need to be aware of. That means anyone involved with:
• Oncology
• Biomarkers
• Molecular/companion diagnostics
• Molecular profiling
• Translational medicine
• Clinical strategy and development
• Regulatory affairs
• R&D strategy/portfolio management
• Pharmacogenomics/pharmacogenetics
• Pathology

To register simply:
Call: +44 20 3141 8700
Email: info@hansonwade.com
Visit: www.pgx-summit.com


Poststrasse 8